GN
Genscript Biotech Corporation
GNNSF · OTC
$4.10 +0.00% (+$0.00)
1M +10.81%
Market Cap $8.96B
P/E Ratio -
Div. Yield -
ROE 12.87%
Bulios Fair Price
$2.61
36.3% downside
Trenutna cena
$4.1
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica GNNSF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
22 /100
Expensive P/B 2.26x
EV/EBITDA 28.22x
P/FCF 37.06x
Growth
91 /100
Growing Book val. growth 57.64%
Rev. growth 15.37%
FCF growth N/A
Profitability
80 /100
Strong Op. margin 26.60%
Gross margin 57.65%
FCF margin 25.15%
Quality
16 /100
Poor ROA 11.00%
ROIC 6.30%
Asset turnover 0.20x
Debt
91 /100
Low Int. coverage 14.76x
Debt/Equity 0.13x
Net debt/EBITDA 1.06x
Stability
26 /100
Unstable EPS volatility 1,810.42%
Beta 0.85x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o GNNSF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Weihui Shao
Employees
6,165
Headquarters
Hong Kong
Prihajajoči dogodki
24 MAR.
Earnings
Upcoming earnings report